Algernon Pharmaceuticals Inc (AGNPF)

[GVX808]

This video further elaborates on Algernon Pharmaceuticals / Algernon NeuroScience going forward.

Youtube link did not want to cooperate. Let’s try this one:

https://www.proactiveinvestors.com/companies/news/1002332/algernon-pharmaceuticals-forms-algernon-neuroscience-subsidiary-to-advance-dmt-stroke-program-1002332.html

As much as I would like to see Algernon Pharmaceuticals continue to be an Ifenprodil/IPF&CC, Repirinast/CKD, and DMT/Stroke play, it looks like:
- Algernon Pharmaceuticals will be Ifenprodil/IPF and Repirinast/CKD
- Algernon NeuroScience will be solely DMT/Stroke.

In the end, it’s all about exploring different ways for Algernon Pharmaceutical’s to raise cash. Can’t say I blame them, but it’s obviously not ideal for longterm AGN/AGNPF shareholders who wanted a piece of all three.

IMO Ifenprodil/IPF has great potential to be the short term big money maker.
No recent news on Repirinast/CKD, so that remains to be seen.

DMT/Stroke is still a bit down the road.